A new study on glaucoma, a leading cause of irreversible blindness, offers a fresh understanding of how the disease ...

The study by OHSU researchers unlocks potential new treatment options for a leading cause of blindness In a new study, OHSU ...

10 Three of these surgical options — goniotomy, trabeculotomy, and canaloplasty — involve creating openings in the trabecular meshwork or modifying existing ones. Using a surgical incision or an ...

Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for ...

The Company’s OMNI ® Surgical System is an implant-free glaucoma surgery technology (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma ...

Meanwhile utanediol mononitrate releases NO to increase outflow through the trabecular meshwork and Schlemm's canal, which drain fluids from the eye. In glaucoma patients, damage to the trabecular ...

The eye constantly makes and releases this fluid. In a healthy eye, excess aqueous humor exits through the trabecular meshwork, which are canals located between your iris (the colored part of the ...

Canaloplasty is a surgical procedure for glaucoma that targets main structures that channel the outflow of aqueous fluid at the front of the eye, such as the trabecular meshwork, Schlemm’s canal ...

Akums launches novel ripasudil+timolol combination for glaucoma and ocular hypertension: Our Bureau, Bengaluru Tuesday, April 1, 2025, 16:40 Hrs [IST] Akums Drugs & Pharmaceutical ...

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a significant growth in short interest in March. As ...

Press Release Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Results expected in May 2025 Last ...